Stryker Current Deferred Revenue vs Good Will Analysis
SYK Stock | USD 384.85 5.29 1.36% |
Stryker financial indicator trend analysis is much more than just breaking down Stryker prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stryker is a good investment. Please check the relationship between Stryker Current Deferred Revenue and its Good Will accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
Current Deferred Revenue vs Good Will
Current Deferred Revenue vs Good Will Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stryker Current Deferred Revenue account and Good Will. At this time, the significance of the direction appears to have strong relationship.
The correlation between Stryker's Current Deferred Revenue and Good Will is 0.79. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Good Will in the same time period over historical financial statements of Stryker, assuming nothing else is changed. The correlation between historical values of Stryker's Current Deferred Revenue and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Stryker are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Current Deferred Revenue i.e., Stryker's Current Deferred Revenue and Good Will go up and down completely randomly.
Correlation Coefficient | 0.79 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Most indicators from Stryker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stryker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.At this time, Stryker's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 116.9 B this year, although the value of Tax Provision will most likely fall to about 289.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 11.0B | 11.6B | 13.1B | 13.7B | Total Revenue | 17.1B | 18.4B | 20.5B | 21.5B |
Stryker fundamental ratios Correlations
Click cells to compare fundamentals
Stryker Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Stryker fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 30.2B | 34.3B | 34.6B | 36.9B | 39.9B | 41.9B | |
Short Long Term Debt Total | 11.1B | 14.0B | 12.5B | 13.0B | 13.0B | 13.6B | |
Other Current Liab | 2.9B | 3.5B | 3.4B | 3.3B | 3.8B | 4.0B | |
Total Current Liabilities | 4.4B | 5.0B | 4.5B | 6.3B | 7.9B | 8.3B | |
Total Stockholder Equity | 12.8B | 13.1B | 14.9B | 16.6B | 18.6B | 19.5B | |
Property Plant And Equipment Net | 2.6B | 2.8B | 2.8B | 3.0B | 3.2B | 3.4B | |
Net Debt | 5.9B | 10.3B | 9.5B | 11.2B | 10.0B | 10.5B | |
Retained Earnings | 11.7B | 12.5B | 13.5B | 14.8B | 16.8B | 17.6B | |
Cash | 4.3B | 2.9B | 2.9B | 1.8B | 3.0B | 3.1B | |
Non Current Assets Total | 18.8B | 24.6B | 24.6B | 26.6B | 27.4B | 28.8B | |
Non Currrent Assets Other | 1.4B | 2.0B | 2.2B | 2.4B | 2.7B | 2.8B | |
Cash And Short Term Investments | 4.4B | 3.0B | 3.0B | 1.9B | 3.1B | 1.7B | |
Net Receivables | 2.9B | 2.7B | 3.0B | 3.6B | 3.8B | 4.0B | |
Liabilities And Stockholders Equity | 30.2B | 34.3B | 34.6B | 36.9B | 39.9B | 41.9B | |
Non Current Liabilities Total | 13.0B | 16.2B | 15.2B | 14.0B | 13.4B | 14.1B | |
Inventory | 3.3B | 3.5B | 3.3B | 4.0B | 4.8B | 5.1B | |
Other Current Assets | 760M | 488M | 662M | 1.5B | 857M | 542.0M | |
Other Stockholder Equity | 1.6B | 1.7B | 1.9B | 2.0B | 2.2B | 2.3B | |
Total Liab | 17.4B | 21.2B | 19.8B | 20.3B | 21.3B | 22.4B | |
Total Current Assets | 11.4B | 9.7B | 10.0B | 10.3B | 12.5B | 13.1B | |
Short Term Debt | 859M | 761M | 7M | 1.3B | 2.2B | 2.3B | |
Intangible Assets | 4.2B | 5.6B | 4.8B | 4.9B | 4.6B | 4.8B | |
Accounts Payable | 675M | 810M | 1.1B | 1.4B | 1.5B | 1.6B | |
Property Plant And Equipment Gross | 2.6B | 2.8B | 5.5B | 5.8B | 6.3B | 6.7B | |
Accumulated Other Comprehensive Income | (606M) | (1.2B) | (531M) | (221M) | (416M) | (395.2M) | |
Short Term Investments | 88M | 81M | 75M | 84M | 82M | 77.9M | |
Good Will | 9.1B | 12.8B | 12.9B | 14.9B | 15.2B | 16.0B | |
Other Liab | 2.4B | 3.0B | 2.7B | 1.8B | 2.0B | 1.1B | |
Other Assets | 2.6B | 3.5B | 4.0B | 3.9B | 4.5B | 4.7B | |
Long Term Debt | 10.2B | 13.2B | 12.5B | 11.9B | 10.9B | 11.4B | |
Property Plant Equipment | 2.6B | 2.8B | 2.8B | 3.0B | 3.4B | 3.6B | |
Net Tangible Assets | (489M) | (5.2B) | (2.9B) | (3.1B) | (2.8B) | (2.7B) | |
Retained Earnings Total Equity | 11.7B | 12.5B | 13.5B | 14.8B | 17.0B | 10.2B | |
Capital Surpluse | 1.6B | 1.7B | 1.9B | 2.0B | 2.3B | 1.5B | |
Non Current Liabilities Other | 2.7B | 3.0B | 1.8B | 1.5B | 1.9B | 1.8B | |
Accumulated Depreciation | (2.1B) | (2.4B) | (2.7B) | (2.8B) | (2.6B) | (2.7B) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.2 | Dividend Share 3.2 | Earnings Share 9.32 | Revenue Per Share 57.728 | Quarterly Revenue Growth 0.119 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.